David B. Musket

CIK: 0001310611

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAPR

CAPRICOR THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
15.5K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
11.9K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
6.5K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
5.8K shares-

		Type	Shares	Price		Ownership
Jan 5, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	15,500	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	11,940	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	6,480	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	5,750	-	-	Direct

1-4 of 4 transactions

About Musket David B

Musket David B (SEC CIK 0001310611) files insider reports with the SEC as Director of CAPRICOR THERAPEUTICS, INC. (CAPR).

Signal8 holds 2 ownership filings by Musket David B, all Form 4s, filed between Jan 6, 2025 and Jan 7, 2026. Those filings report 4 transactions, from Jan 2, 2025 to Jan 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Musket David B's filings is in SAN DIEGO, CA.

Recent filings by Musket David B

Jan 5, 2026: Grant or award of CAPR derivative securities (Form 4, code A).
Jan 2, 2025: Grants or awards of CAPR derivative securities (3 lines, Form 4, code A).

Other insiders filing for CAPRICOR THERAPEUTICS, INC. (CAPR)

Krasney Karen, EVP, GENERAL COUNSEL
Bergmann Anthony, CHIEF FINANCIAL OFFICER
Maurer Michael T, CHIEF COMMERCIAL OFFICER
Litvack Frank, Director
Sabar Karimah Es, Director
Marban Linda, CHIEF EXECUTIVE OFFICER

How to read Form 4 transaction codes